Contracts Finder · Award
RADIOPHARMACEUTICALS AND GENERATORS
A public procurement published by HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST via Contracts Finder.
- £1.1m
- Award value
- £1.1m
- Tender value
- 2
- Suppliers
- 2
- Awards
- 1
- Notices
- Award
- Stage
Overview
For the supply of radiopharmaceuticals and associated consumables. The Trust has awarded the contract via North of England Commercial Procurement Collaborative Framework Agreement.
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 09344000 — Radio-isotopes
- Currency
- GBP
- Total award value
- £1,052,733
- Tender value
- £1,052,733
- First published
- 11 Jun 2019
- Last updated
- 11 Jun 2019
Awards
2 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Curium Pharma | — | 25 Apr 2019 | active | £1.1m |
| GE Healthcare LTD | 01002610 | 25 Apr 2019 | active | £1.1m |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST
FAQs about this procurement
Who is the buyer for "RADIOPHARMACEUTICALS AND GENERATORS"?
RADIOPHARMACEUTICALS AND GENERATORS is a UK public-sector procurement published by HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST via Contracts Finder.
Has "RADIOPHARMACEUTICALS AND GENERATORS" been awarded?
Yes — 2 awards are recorded, with a reported total value of £1,052,733. The current lifecycle stage is "Award".
Which suppliers are involved in "RADIOPHARMACEUTICALS AND GENERATORS"?
2 suppliers are linked: Curium Pharma, GE Healthcare LTD.
What is "RADIOPHARMACEUTICALS AND GENERATORS" worth?
The reported award value is £1,052,733.
When was "RADIOPHARMACEUTICALS AND GENERATORS" published?
It was first published on 11 Jun 2019 and last updated on 11 Jun 2019, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable